Literature DB >> 10607723

Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients.

J J Lefrère1, F Roudot-Thoraval, F Lefrère, A Kanfer, M Mariotti, J Lerable, M Thauvin, G Lefèvre, P Rouger, R Girot.   

Abstract

Little is known about the natural history and the pathogenicity of the TT virus (TTV). We present our findings of a cross-sectional study based on the TTV DNA screening of 173 multiple-transfused patients and a longitudinal study based on the follow-up of TTV DNA-positive patients. Overall, 48 patients (27.7%) tested positive for TTV DNA. The influence of the number of blood donor exposures on the prevalence of blood-borne viral infection indicates that TTV, hepatitis C virus (HCV), and an RNA virus known as GB virus C/hepatitis G virus (GBV-C/HGV) share a parenteral transmission, but that TTV, in contrast to the 2 other viruses, is also transmitted by at least another efficient means. The patients having a well-defined date of TTV infection were positive for TTV DNA during a mean period of 3.1 years. A chronic infection was observed in 31 cases (86%). TTV carriage appeared clinically benign in all patients. No clinical evidence of a disease potentially linked to the TTV infection was observed in patients with TTV DNA carriage over several years. The majority of TTV carriers had no biochemical evidence of liver disease. The prevalence of elevated serum alanine aminotransferase (ALT) level was higher in the TTV DNA-positive group, even in the absence of HCV infection, but the observed peaks of ALT level were most often transient and very mild. The prevalence of TTV DNA observed in blood recipients is consistent with that of TTV infection observed in blood donors. TTV infection frequently tends to persist. (Blood. 2000;95:347-351)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607723

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

2.  Low prevalence of transfusion transmitted virus (TTV)-like DNA sequences in cystadenolymphoma and pleomorphic adenoma of the salivary glands.

Authors:  Mathias Wagner; Jens P Klussmann; Olaf Dirsch; Vivienne A Rose; Orlando Guntinas-Lichius; Dirk Theegarten; Holger Sudhoff; Roland Linder
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-16       Impact factor: 2.503

3.  TT virus (TTV) genotyping in blood donors and multiple transfused patients in Brazil.

Authors:  Maria Fernanda de Castro Amarante; Simone Kashima; Dimas Tadeu Covas
Journal:  Virus Genes       Date:  2007-06-15       Impact factor: 2.332

4.  TT-virus infection in Japanese general population and in hemodialysis patients.

Authors:  Yoko Kanamoto-Tanaka; Norihiro Furusyo; Hisashi Nakashima; Yoshitaka Etoh; Seizaburo Kashiwagi; Jun Hayashi
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

5.  Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C.

Authors:  Javier Moreno; Gloria Moraleda; Rafael Barcena; Mluisa Mateos; Santos del Campo
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

6.  TT virus infection in patients with chronic hepatitis B and response of TTV to lamivudine.

Authors:  Javier Moreno Garcia; Rafael Barcena Marugan; Gloria Moraleda Garcia; M Luisa-Mateos Lindeman; Jesus Fortun Abete; Santos Del-Campo Terron
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

7.  Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease.

Authors:  Peter Meerts; Gerald Misinzo; David Lefebvre; Jens Nielsen; Anette Bøtner; Charlotte S Kristensen; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2006-01-30       Impact factor: 2.741

8.  Identification of a new genotype of Torque Teno Mini virus.

Authors:  Seyed Mohammad Jazaeri Farsani; Maarten F Jebbink; Martin Deijs; Marta Canuti; Karel A van Dort; Margreet Bakker; Bart P X Grady; Maria Prins; Formijn J van Hemert; Neeltje A Kootstra; Lia van der Hoek
Journal:  Virol J       Date:  2013-10-30       Impact factor: 4.099

9.  Molecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients.

Authors:  Maha A Al-Mozaini; Mohammed N Al-Ahdal; George Kessie; Damian M Dela Cruz; Mohammed A Rezeig; Fahad J Al-Shammary
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

10.  A novel variant of torque teno virus 7 identified in patients with Kawasaki disease.

Authors:  James B Thissen; Mariko Isshiki; Crystal Jaing; Yoshiro Nagao; Dayanara Lebron Aldea; Jonathan E Allen; Masafumi Izui; Thomas R Slezak; Takafumi Ishida; Tetsuya Sano
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.